Médecine

Paramédical

Autres domaines


Suscribirse

When science goes viral: The research response during three months of the COVID-19 outbreak - 28/08/20

Doi : 10.1016/j.biopha.2020.110451 
Joanna Nowakowska a, 1, Joanna Sobocińska a, 1, Mateusz Lewicki b, Żaneta Lemańska a, Piotr Rzymski c, d,
a Poznan University of Medical Sciences, Fredry 10, 61-701, Poznań, Poland 
b Pomeranian Medical University in Szczecin, Rybacka 1, 70-204, Szczecin, Poland 
c Department of Environmental Medicine, Poznan University of Medical Sciences, Rokietnicka 8, 60-806, Poznań, Poland 
d Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), Poznań, Poland 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

A bibliometric study on the first 3 months of research on COVID-19 was performed.
A total of 2062 articles in 578 journals and 1425 preprints were identified.
The scientific contributions from 73 countries were seen.
The highest number of original research emerged from China.
The scientific response to COVID-19 is unprecedented.

El texto completo de este artículo está disponible en PDF.

Abstract

Here we present the results of a bibliometric survey of peer-reviewed and pre-print papers published in the English language on issues related to COVID-19 within the first three months since a cluster of a severe acute respiratory disease of unknown etiology was officially confirmed by the Chinese Center for Disease Control and Prevention on 31 December 2019. A systematic search using PubMed/Medline and Scopus databases and preprint servers was performed. The articles were classified according to their type, subject and country of origin. Up to 31 March 2020, a total of 2062 papers published in 578 peer-reviewed journals and 1425 preprints posted mostly on medRxiv (55.4 %), were identified. The mean number of published journal papers and preprints per day in the considered period was 27 and 12, respectively, and reached a maximum of 51 and 46 per day in March, respectively. The identified articles, journal papers and preprints, mostly covered the epidemiology of COVID-19 (35.7 %), clinical aspects of infection (21.0 %), preventative measures (12.8 %), treatment options (12.5 %), diagnostics (12.2 %), mathematical modeling of disease transmission and mitigation (9.6 %), and molecular biology and pathogenesis of SARS-CoV-2 (8.7 %). The majority of the journal papers were commentaries (38.5 %), reviews (33.6 %) and original research (21.3 %), while preprints predominantly presented original results (89.8 %). Chinese scientists contributed the highest share of original research and were responsible for 32.9 % journal papers and 43.9 % preprints published in the considered period. A high number of contributions was also seen from the United States, the United Kingdom, and Italy. The benefits and potential risks of such a massive publication output are discussed. The scientific response seen during the first 3 months of the COVID-19 outbreak is a demonstration of the capabilities of modern science to react rapidly to emerging global health threats by providing and discussing the essential information for understanding the etiological factor, its spread, preventative measures, and mitigation strategies.

El texto completo de este artículo está disponible en PDF.

Keywords : COVID-19, SARS-CoV-2, Emerging infectious disease, Bibliometric analysis, Academia


Esquema


© 2020  The Author(s). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 129

Artículo 110451- septembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis
  • Jie Lin, Han-fei Huang, Shi-kun Yang, Jian Duan, Si-ming Qu, Bo Yuan, Zhong Zeng
| Artículo siguiente Artículo siguiente
  • Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain
  • Amal Thomas, Bright N. Okine, David P. Finn, Willias Masocha

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.